Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
2 other identifiers
interventional
115
1 country
1
Brief Summary
Purpose: Obesity is reaching epidemic proportions, affecting 36% of the adult population in the United States. There is intense interest in dietary management to treat obesity and its associated complications. The first line of obesity treatment is caloric restriction (CR), although recidivism is common. For moderate CR, attrition rates of 20% are often reported, therefore weight loss options beyond CR are urgently needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Oct 2020
Longer than P75 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedStudy Start
First participant enrolled
October 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2023
CompletedResults Posted
Study results publicly available
February 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 23, 2026
January 1, 2026
3 years
February 4, 2020
January 30, 2025
January 5, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Weight
Weight will be measured by standard scale and reported in kilograms. This between 2 time points - baseline and 12 weeks
12 weeks
Secondary Outcomes (6)
Change in Whole Body Percent Fat
Baseline, 12 weeks
Change in Visceral Fat
Baseline, 12 weeks
Change in Lean Mass
Baseline, 12 weeks
Change in Fat Mass
Baseline, 12 weeks
Change in Caloric Intake
Baseline, 12 weeks
- +1 more secondary outcomes
Study Arms (3)
Time Restricted Eating (TRE)
EXPERIMENTALFor the TRE group, we will restrict the eating window to 8 hours, where they will eat ad libitum. This is the same interval established by Dr. Panda and by our preliminary data. This interval will be entered into the mCC app and participants will be asked to adhere to this eating window during the intervention. All eating occasions will be logged using the mCC app. Only water and medications will be allowed outside of the eating window.
Caloric Restriction (CR)
ACTIVE COMPARATORParticipants randomized to CR will meet with the study dietitian prior to the intervention and be counseled on options to reduce their caloric intake by 15%, while maintaining their eating window. The 15% reduction was selected as our preliminary data and recent literature suggest that TRE with ad libitum intake reduces caloric intake by \~270 to 300 cal/day. The 15% CR is similar to the 11.9% CR achieved by the CALERIE-2 study, which is a 2 year study of CR.26 All eating occasions will be logged using the mCC app. The weekly dietitian review of the mCC information will include maintenance of the eating window and examination of dietary intake to determine compliance with the 15% CR.
Unrestricted Eating (non-TRE)
NO INTERVENTIONFor the unrestricted eating (non-TRE) group, participants will eat ad libitum per their usual habits. They will receive initial counseling about mCC logging. All eating occasions will be logged using the mCC app.
Interventions
daily eating window restricted to 8 hours
Eligibility Criteria
You may qualify if:
- BMI ≥30 and ≤ 55 kg/m\^2
- Own a smartphone compatible with the myCircadianClock (mCC) phone application
- Self-reported habitual wakening between 5-9 am
- Self reported sleep duration of 6-9 hours
- Weight must be stable \[+/- 5 pounds\] for at least 3 months prior to the study
- Eating window (time between 1st food intake and last food take) ≥14 hours using mCC
- Insulin resistance based on HOMA-IR≥ 2.5 from screening visit results
- Able to understand English
You may not qualify if:
- Use of beta-blockers or medications known to affect weight, such as thiazolidinedione (TZD), insulin, glucagon-like peptide (GLP)-1 agonists, phentermine, or sibutamine
- Shift work (i.e. working from 11pm to 7am)
- Clinically significant medical issues (diabetes, cardiovascular disease, uncontrolled pulmonary disease)
- A history of abnormal laboratory results, such as hematologic (platelets \< 100), hepatic (LFTs \> 2X nl), renal (Cr \> 1.5)
- MRI contraindication (metal in body, claustrophobia)
- Eating window \< 12 hours per day
- Unable to consistently document food intake using the mCC app (need at least 2 eating occasions\> 6 hours apart on a given day for at least 50% of days)
- Pregnancy
- Illiteracy
- Concern for active eating disorder per screening questionnaire
- Self-reported eating disorder or history of eating disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Related Publications (1)
Chen DA, Pena RH, Oldenburg N, Wang Q, Helgeson E, Yentzer B, Taddese A, LaPage N, Manoogian ENC, Panda S, Chow LS. Post-intervention sustainability of time-restricted eating versus caloric restriction: a secondary analysis. Int J Obes (Lond). 2026 Feb;50(2):474-477. doi: 10.1038/s41366-025-01968-2. Epub 2025 Nov 28.
PMID: 41315749DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Niki Oldenburg
- Organization
- University of Minnesota
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 6, 2020
Study Start
October 15, 2020
Primary Completion
October 12, 2023
Study Completion
December 31, 2025
Last Updated
January 23, 2026
Results First Posted
February 24, 2025
Record last verified: 2026-01